Vol. XVIII · Free shipping $75+ · Read the collection
Login Register
Feature · Product Review
foxo4 dri senolytic peptide study

foxo4 dri senolytic peptide study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis The disordered p53 transactivation domain

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI 10mg Senolytic Research Peptide Kalyx Labs FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway

SKU: 25825226071 · From creatorsinfotech.com

4.2
USD27.15 USD68.15

Pay in 4 interest-free payments of $6.79 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 27 - Nov 1

Description

Most therapeutic peptides have relatively short half-lives minutes to hours which is why consistent daily dosing is required during an active cycle

foxo4 dri senolytic peptide study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis The disordered p53 transactivation domain

Lyophilized peptides are typically stable at room temperature for several weeks, making it suitable for moderate-term storage

foxo4 dri senolytic peptide study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis The disordered p53 transactivation domain

Effects of GHK-Cu on MMP and TIMP expression, collagen and elastin production, and facial wrinkle parameters

foxo4 dri senolytic peptide study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis The disordered p53 transactivation domain

Test new options to find your go-to

foxo4 dri senolytic peptide study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis The disordered p53 transactivation domain

View all reviews Good experience overall

foxo4 dri senolytic peptide study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis The disordered p53 transactivation domain
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products

NutriDyn

US$ 20.36

Min. order: 1 piece

4.2 (9 reviews)

Sold : Login>>